| The risk of allergic reaction to SARS-CoV-2 vaccines and recommended evaluation and management: a systematic review, meta-analysis, GRADE assessment, and international … M Greenhawt, EM Abrams, M Shaker, DK Chu, D Khan, C Akin, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (10), 3546-3567, 2021 | 223 | 2021 |
| Novel coronavirus COVID-19: current evidence and evolving strategies C Vannabouathong, T Devji, S Ekhtiari, Y Chang, SA Phillips, M Zhu, ... JBJS 102 (9), 734-744, 2020 | 155 | 2020 |
| The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19≥ 7 days after the 2nd dose Z Chagla Annals of internal medicine 174 (2), JC15, 2021 | 135 | 2021 |
| Re: it is time to address airborne transmission of COVID-19 Z Chagla, S Hota, S Khan, D Mertz, ... Clinical Infectious Diseases 73 (11), e3981-e3982, 2021 | 69 | 2021 |
| Safety of hydroxychloroquine among outpatient clinical trial participants for COVID-19 SM Lofgren, MR Nicol, AS Bangdiwala, KA Pastick, EC Okafor, ... Open forum infectious diseases 7 (11), ofaa500, 2020 | 61 | 2020 |
| Medical masks versus N95 respirators for preventing COVID-19 among health care workers: a randomized trial M Loeb, A Bartholomew, M Hashmi, W Tarhuni, M Hassany, I Youngster, ... Annals of internal medicine 175 (12), 1629-1638, 2022 | 60 | 2022 |
| The efficacy and safety of hydroxychloroquine for COVID-19 prophylaxis: A systematic review and meta-analysis of randomized trials K Lewis, D Chaudhuri, F Alshamsi, L Carayannopoulos, K Dearness, ... PLoS one 16 (1), e0244778, 2021 | 57 | 2021 |
| Prescribing nirmatrelvir/ritonavir for COVID-19 in advanced CKD S Hiremath, M McGuinty, C Argyropoulos, KS Brimble, PA Brown, ... Clinical Journal of the American Society of Nephrology 17 (8), 1247-1250, 2022 | 52 | 2022 |
| Characteristics of anti-SARS-CoV-2 antibodies in recovered COVID-19 subjects A Huynh, DM Arnold, JW Smith, JC Moore, A Zhang, Z Chagla, BJ Harvey, ... Viruses 13 (4), 697, 2021 | 44* | 2021 |
| Chronic norovirus infection in a transplant patient successfully treated with enterally administered immune globulin Z Chagla, J Quirt, K Woodward, J Neary, C Rutherford Journal of Clinical Virology 58 (1), 306-308, 2013 | 42 | 2013 |
| In adults, the Oxford/AstraZeneca vaccine had 70% efficacy against COVID-19> 14 d after the 2nd dose Z Chagla Annals of Internal Medicine 174 (3), JC29, 2021 | 33 | 2021 |
| COVID-19 boosters in rich nations will delay vaccines for all Z Chagla, M Pai Nature Medicine 27 (10), 1659-1660, 2021 | 32 | 2021 |
| In high-risk adults, the Moderna vaccine had 94% efficacy against COVID-19≥ 14 d after the 2nd dose Z Chagla Annals of Internal Medicine 174 (3), JC28, 2021 | 29 | 2021 |
| Early experience with modified dose nirmatrelvir/ritonavir in dialysis patients with coronavirus disease 2019 S Hiremath, PG Blake, A Yeung, M McGuinty, D Thomas, J Ip, PA Brown, ... Clinical Journal of the American Society of Nephrology 18 (4), 485-490, 2023 | 20 | 2023 |
| Utility of asymptomatic inpatient testing for COVID-19 in a low-prevalence setting: a multicenter point-prevalence study AD Bai, XX Li, M Alsalem, S Khan, M Smieja, D Mertz, Z Chagla Infection Control & Hospital Epidemiology 41 (10), 1233-1235, 2020 | 20 | 2020 |
| Assessment of the burden of SARS-CoV-2 variants of concern among essential workers in the greater Toronto area, Canada Z Chagla, H Ma, B Sander, SD Baral, G Moloney, S Mishra JAMA Network Open 4 (10), e2130284-e2130284, 2021 | 19 | 2021 |
| Monoclonal antibodies as COVID-19 prophylaxis therapy in immunocompromised patient populations J Cowan, A Amson, A Christofides, Z Chagla International Journal of Infectious Diseases, 2023 | 17 | 2023 |
| In South Africa, a 2-dose Oxford/AZ vaccine did not prevent mild to moderate COVID-19 (cases mainly B. 1.351 variant) N Irfan, Z Chagla Annals of Internal Medicine 174 (5), JC50, 2021 | 14 | 2021 |
| Melioidosis in a returned traveller Z Chagla, N Aleksova, J Quirt, J Emery, C Kraeker, S Haider Canadian Journal of Infectious Diseases and Medical Microbiology 25 (4), 225-226, 2014 | 14 | 2014 |
| Disseminated Cryptococcal Disease in Non‐HIV, Nontransplant Patient F AlMutawa, D Leto, Z Chagla Case Reports in Infectious Diseases 2016 (1), 1725287, 2016 | 10 | 2016 |
